Effusion cytology: |
|
|
breast carcinoma |
10/111 |
|
lung carcinoma |
6/71 |
|
gastrointestinal carcinoma |
9/91 |
|
ovarian carcinoma |
7/81 |
|
other carcinomas |
3/51 |
|
carcinomas overall |
35/401 |
|
reactive mesothelium |
||
mesothelioma |
3/31 |
There is inadequate evidence as to whether heparanase is useful in the distinction of benign mesothelium from malignant mesothelioma. There are other markers that are much better established for distinguishing carcinoma from mesothelial cells.
References
This page last revised 15.2.2007.
©SMUHT/PW Bishop